TGFA and neoplasm: Tumor cells overexpressing TGF-α display both primary and acquired resistance to kinase inhibitors, including anaplastic lymphoma kinase (ALK) and mesenchymal-epithelial transition factor (c-Met) inhibitors, by maintaining pro-survival signaling and inhibiting apoptosis, underscoring its role as a central mediator of drug resistance[69].